T-2345
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T-2345, covering 2018-08-22 to 2018-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]